Foukas Joshua, Chief Legal Officer of USANA Health Sciences (USNA), has demonstrated a consistent pattern of selling activity over the past three years, with no recorded purchases in SEC filings. Since 2024, Joshua has executed 30 transactions exclusively involving USNA shares, all of which were sales or dispositions, totaling approximately $964,502 in aggregate value. The most recent transactions occurred in February 2026, with sales of $95,220 on February 20 and $59,954 on February 27, following earlier dispositions of $33,845 and smaller amounts earlier that month. This follows a similar pattern in prior years, including a $186,513 sale in March 2025 and a $232,234 transaction in February 2024.
The filings indicate that Joshua’s dispositions are often preceded by smaller transactions coded as gifts or other non-sale transfers (marked "F" or "M" with $0 value), suggesting a structured approach to reducing holdings. The absence of any buys—coupled with repeated sales—points to a clear divestment trend rather than accumulation. While the reasons for these transactions are not disclosed, the data reflects a sustained reduction in exposure to USNA stock over time, with the most recent activity continuing this directional bias. The sales, ranging from mid-five to low-six figures annually, represent a notable portion of Joshua’s disclosed equity activity in the company.
AI-assisted summary